Literature DB >> 24758183

Adrenal nodularity and somatic mutations in primary aldosteronism: one node is the culprit?

T Dekkers1, M ter Meer, J W M Lenders, A R M Hermus, L Schultze Kool, J F Langenhuijsen, K Nishimoto, T Ogishima, K Mukai, E A B Azizan, B Tops, J Deinum, B Küsters.   

Abstract

CONTEXT: Somatic mutations in genes that influence cell entry of calcium have been identified in aldosterone-producing adenomas (APAs) of adrenal cortex in primary aldosteronism (PA). Many adrenal glands removed for suspicion of APA do not contain a single adenoma but nodular hyperplasia.
OBJECTIVE: The objective of the study was to assess multinodularity and phenotypic and genotypic characteristics of adrenals removed because of the suspicion of APAs. DESIGN AND METHODS: We assessed the adrenals of 53 PA patients for histopathological characteristics and immunohistochemistry for aldosterone (P450C18) and cortisol (P450C11) synthesis and for KCNJ5, ATP1A1, ATP2B3, and CACNA1D mutations in microdissected nodi.
RESULTS: Glands contained a solitary adenoma in 43% and nodular hyperplasia in 53% of cases. Most adrenal glands contained only one nodule positive for P450C18 expression, with all other nodules negative. KCNJ5 mutations were present in 22 of 53 adrenals (13 adenoma and nine multinodular adrenals). An ATP1A1 and a CACNA1D mutation were found in one multinodular gland each and an ATP2B3 mutation in five APA-containing glands. Mutations were always located in the P450C18-positive nodule. In one gland two nodules containing two different KCNJ5 mutations were present. Zona fasciculata-like cells were more typical for KCNJ5 mutation-containing nodules and zona glomerulosa-like cells for the other three genes.
CONCLUSIONS: Somatic mutations in KCNJ5, ATP1A1, or CACNA1D genes are not limited to APAs but are also found in the more frequent multinodular adrenals. In multinodular glands, only one nodule harbors a mutation. This suggests that the occurrence of a mutation and nodule formation are independent processes. The implications for clinical management remain to be determined.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24758183     DOI: 10.1210/jc.2013-4255

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  47 in total

1.  Different Somatic Mutations in Multinodular Adrenals With Aldosterone-Producing Adenoma.

Authors:  Fabio Luiz Fernandes-Rosa; Isabelle Giscos-Douriez; Laurence Amar; Celso E Gomez-Sanchez; Tchao Meatchi; Sheerazed Boulkroun; Maria-Christina Zennaro
Journal:  Hypertension       Date:  2015-09-08       Impact factor: 10.190

2.  Histopathological and genetic characterization of aldosterone-producing adenomas with concurrent subclinical cortisol hypersecretion: a case series.

Authors:  Francesco Fallo; Isabella Castellano; Celso E Gomez-Sanchez; Yara Rhayem; Catia Pilon; Valentina Vicennati; Donatella Santini; Valeria Maffeis; Ambrogio Fassina; Paolo Mulatero; Felix Beuschlein; Martin Reincke
Journal:  Endocrine       Date:  2017-04-12       Impact factor: 3.633

3.  Primary Aldosteronism: KCNJ5 Mutations and Adrenocortical Cell Growth.

Authors:  Yuhong Yang; Celso E Gomez-Sanchez; Diana Jaquin; Elke Tatjana Aristizabal Prada; Lucie S Meyer; Thomas Knösel; Holger Schneider; Felix Beuschlein; Martin Reincke; Tracy Ann Williams
Journal:  Hypertension       Date:  2019-08-26       Impact factor: 10.190

4.  Genetic Characteristics of Aldosterone-Producing Adenomas in Blacks.

Authors:  Kazutaka Nanba; Kei Omata; Celso E Gomez-Sanchez; Constantine A Stratakis; Andrew P Demidowich; Mari Suzuki; Lester D R Thompson; Debbie L Cohen; James M Luther; Lan Gellert; Anand Vaidya; Justine A Barletta; Tobias Else; Thomas J Giordano; Scott A Tomlins; William E Rainey
Journal:  Hypertension       Date:  2019-04       Impact factor: 10.190

Review 5.  Hyperaldosteronism: How to Discriminate Among Different Disease Forms?

Authors:  Valentina Crudo; Silvia Monticone; Jacopo Burrello; Fabrizio Buffolo; Martina Tetti; Franco Veglio; Paolo Mulatero
Journal:  High Blood Press Cardiovasc Prev       Date:  2016-05-02

Review 6.  Review of Markers of Zona Glomerulosa and Aldosterone-Producing Adenoma Cells.

Authors:  Teresa M Seccia; Brasilina Caroccia; Elise P Gomez-Sanchez; Paul-Emmanuel Vanderriele; Celso E Gomez-Sanchez; Gian Paolo Rossi
Journal:  Hypertension       Date:  2017-09-25       Impact factor: 10.190

Review 7.  Immunohistochemistry of aldosterone synthase leads the way to the pathogenesis of primary aldosteronism.

Authors:  Koshiro Nishimoto; Minae Koga; Tsugio Seki; Kenji Oki; Elise P Gomez-Sanchez; Celso E Gomez-Sanchez; Mitsuhide Naruse; Tomokazu Sakaguchi; Shinya Morita; Takeo Kosaka; Mototsugu Oya; Tadashi Ogishima; Masanori Yasuda; Makoto Suematsu; Yasuaki Kabe; Masao Omura; Tetsuo Nishikawa; Kuniaki Mukai
Journal:  Mol Cell Endocrinol       Date:  2016-10-14       Impact factor: 4.102

Review 8.  Somatic mutations of the ATP1A1 gene and aldosterone-producing adenomas.

Authors:  Celso E Gomez-Sanchez; Maniselvan Kuppusamy; Elise P Gomez-Sanchez
Journal:  Mol Cell Endocrinol       Date:  2014-12-10       Impact factor: 4.102

Review 9.  Immunohistochemical Biomarkers of Adrenal Cortical Neoplasms.

Authors:  Ozgur Mete; Sylvia L Asa; Thomas J Giordano; Mauro Papotti; Hironobu Sasano; Marco Volante
Journal:  Endocr Pathol       Date:  2018-06       Impact factor: 3.943

Review 10.  Primary Aldosteronism: Practical Approach to Diagnosis and Management.

Authors:  James Brian Byrd; Adina F Turcu; Richard J Auchus
Journal:  Circulation       Date:  2018-08-21       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.